Literature DB >> 31880044

Establishing a rapid classification and identification method for the major triterpenoids of Alisma orientale.

Na Yang1, Ya-Qian Dong1, Meng-Fan Wu1, Shan-Ze Li1, Hong-Xin Yu1, Shen-Shen Yang1.   

Abstract

INTRODUCTION: Alismatis Rhizoma (AR) has been widely used to treat various diseases. Its complex chemical composition has caused certain difficulties in the analysis of this traditional Chinese medicine. Therefore, it is necessary to establish a method for the rapid classification and identification of the chemical constituents of AR.
OBJECTIVE: This article describes a method for the rapid classification and identification of major triterpenoids in AR.
METHODOLOGY: The samples were analysed by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS). The assay was performed on a Waters ACQUITY UPLC BEH C18 column (100 mm × 2.1 mm, 1.7 μm) with 0.1% formic acid in water (A), and acetonitrile (B) as mobile phase by gradient elution at a flow rate of 0.3 mL/min. In the positive ion mode, the fragment information was obtained and compared with the characteristic fragments and neutral losses described in the literature. Then, the rapid classification and identification of the chemical components from AR were achieved.
RESULTS: Finally, 25 triterpene compounds of AR were identified.
CONCLUSIONS: The method established in this study achieved the rapid classification and identification of chemical components in AR, which promotes the development of research methods to study the constituents of traditional Chinese medicine.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Alismatis Rhizoma; UPLC-Q-TOF-MS; characteristic fragments; fragmentation process; neutral losses

Mesh:

Substances:

Year:  2019        PMID: 31880044     DOI: 10.1002/pca.2907

Source DB:  PubMed          Journal:  Phytochem Anal        ISSN: 0958-0344            Impact factor:   3.373


  6 in total

1.  Integrated Strategy From In Vitro, In Situ, In Vivo to In Silico for Predicting Active Constituents and Exploring Molecular Mechanisms of Tongfengding Capsule for Treating Gout by Inhibiting Inflammatory Responses.

Authors:  Wenning Yang; Xiaoquan Jiang; Jingtong Liu; Dongying Qi; Zhiqiang Luo; Guohua Yu; Xueyan Li; Muli Sen; Hongjiao Chen; Wei Liu; Yang Liu; Guopeng Wang
Journal:  Front Pharmacol       Date:  2021-11-29       Impact factor: 5.810

2.  Rapid Identification of Characteristic Chemical Constituents of Panax ginseng, Panax quinquefolius, and Panax japonicus Using UPLC-Q-TOF/MS.

Authors:  Liu Jinbiao; Zhang Xinyue; Yang Shenshen; Wang Shuo; Liu Chengcheng; Yang Bin; Li Yubo; Cai Ting
Journal:  J Anal Methods Chem       Date:  2022-02-15       Impact factor: 2.193

Review 3.  Pharmacological Properties and Molecular Targets of Alisol Triterpenoids from Alismatis Rhizoma.

Authors:  Christian Bailly
Journal:  Biomedicines       Date:  2022-08-11

4.  Alismatis Rhizoma methanolic extract-Effects on metabolic syndrome and mechanisms of triterpenoids using a metabolomic and lipidomic approach.

Authors:  Li Jia; Min Zhang; Pengli Wang; Liming Wang; Peng Lei; Ruijiao Du; Lifeng Han; Peng Zhang; Yuefei Wang; Miaomiao Jiang
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

5.  Dissection of the Active Ingredients and Potential Mechanism of Han-Shi-Yu-Fei-Decoction in Treating COVID-19 Based on In Vivo Substances Profiling and Clinical Symptom-Guided Network Pharmacology.

Authors:  Guangyang Jiao; Xiangcheng Fan; Yejian Wang; Nan Weng; Luolan Ouyang; Haoqian Wang; Sihan Pan; Doudou Huang; Jun Han; Feng Zhang; Wansheng Chen
Journal:  ACS Omega       Date:  2022-10-07

6.  Qualitative Analysis of Drug-Containing Plasma and its Application to Quantitative Analysis and Pharmacokinetic Study of Zexie Decoction Using UPLC-MS/MS.

Authors:  Jiashuo Wu; Shunliang Zheng; Fangqing Zhang; Haonan Ruan; Haotian Xue; Jingxun Wang; Zhuangzhuang Li; Weiyi Jin; Weihua Wang; Jing Xia; Yue Shi
Journal:  Front Chem       Date:  2022-02-22       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.